IdB 1016 in Hepatitis C.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Silipide (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 01 Sep 2006 Status change
- 01 Sep 2006 The expected completion date for this trial is now .
- 03 Oct 2005 New trial record.